Combatting The 'Bad Trip': New Research Project Seeks Solutions That Go Beyond Psychedelics
Ehave, Inc. (OTC: EHVVF) has completed the first of three planned phases of its studies with the University of Melbourne to determine the cause and possible cure for hallucinogen-persisting perception disorder (HPPD).